Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor control probability models

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 5, 2000, Pages 1245-1260

  Levegrün, Sabine ^a,b   Jackson, Andrew ^a   Zelefsky, Michael J ^a   Venkatraman, Ennapadam S ^a   Skwarchuk, Mark W ^a   Schlegel, Wolfgang ^b   Fuks, Zvi ^a   Leibel, Steven A ^a   Ling, C Clifton ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Biopsy; Conformal radiotherapy; Dose distribution; Prostate cancer; Tumor control probability models

Indexed keywords

ARTICLE; CANCER CONTROL; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PROSTATE CANCER; RADIATION DOSE DISTRIBUTION; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; STATISTICAL MODEL; SYSTEM ANALYSIS; TUMOR BIOPSY;

ANALYSIS OF VARIANCE; BIOPSY; HUMANS; MALE; MODELS, STATISTICAL; PROSTATE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; REGRESSION ANALYSIS; ROC CURVE;

EID: 0034662073     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00572-1     Document Type: Article

References (36)

1. Drzymala R.E., Mohan R., Brewster L., et al. Dose-volume histograms. Int J Radiat Oncol Biol Phys. 21:(1):1991;71-78.
2. Goitein M. The probability of controlling an inhomogeneously irradiated tumor. Zink S. Evaluation of treatment planning for particle beam radiotherapy. 1987;5.8.1-5.8.17 National Cancer Institute, Bethesda, MD.
3. Niemierko A., Goitein M. Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor. Radiother Oncol. 29:1993;140-147.
4. Nahum A.E., Tait D.M. Maximizing local control by customized dose prescription for pelvic tumours. Breit A. Advanced radiation therapy tumor response monitoring and treatment planning. 1992;425-431 Springer-Verlag, Heidelberg.
5. Brenner D.J. Dose, volume, and tumour-control predictions in radiotherapy. Int J Radiat Oncol Biol Phys. 26:1993;171-179.
6. Webb S., Nahum A.E. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneuos distributions of dose and clonogenic cell density. Phys Med Biol. 38:1993;653-666.
7. Webb S. Optimum parameters in a model for tumour control probability including interpatient heterogeneity. Phys Med Biol. 39:1994;1895-1914.
8. Wu P.M., Chua D.T.T., Sham J.S.T., et al. Tumor control probability of nasopharyngeal carcinoma A comparison of different mathematical models . Int J Radiat Oncol Biol Phys. 37:(4):1997;913-920.
9. Niemierko A. Reporting and analyzing dose distributions A concept of equivalent uniform dose . Med Phys. 24:(1):1997;103-110.
10. Brahme A. Dosimetric precision requirements in radiation therapy. Acta Radiol Oncol. 23:1984;379-391.
11. Deasy J. Tumor control probability models for nonuniform dose distributions. Paliwal B.R., Fowler J.F., Herbert D.E., et al. Volume and kinetics in tumor control and normal tissue complications. 1998;65-85 Medical Physics Publishing, Madison, WI.
12. Niemierko A. A concept of equivalent uniform dose (EUD). Paliwal B.R., Fowler J.F., Herbert D.E., et al. Volume and kinetics in tumor control and normal tissue complications. 1998;86-91 Medical Physics Publishing, Madison, WI.
13. Leibel S.A., Heimann R., Kutcher G.J., et al. Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate Preliminary results of a phase I dose-escalation study . Int J Radiat Oncol Biol Phys. 28:1994;55-65.
14. Leibel S.A., Zelefsky M.J., Kutcher G.J., et al. Three-dimensional conformal radiation therapy in localized carcinoma of the prostate Interim report of a phase I dose-escalation study . J Urol. 152:1994;1792-1798.
15. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 41:(3):1998;491-500.
16. Leibel S.A., Zelefsky M.J., Kutcher G.J., et al. The biological basis and clinical application of three-dimensional conformal external beam radiation therapy in carcinoma of the prostate. Semin Oncol. 21:(5):1994;580-597.
17. Ling C.C., Burman C., Chui C.S., et al. Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. Int J Radiat Oncol Biol Phys. 35:(4):1996;721-730.
18. American Joint Committee on Cancer: Prostate. In: Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, editors. Manual for staging of cancer. 4th ed. Philadelphia: JB Lippincott; 1992. p. 181-183.
19. Gleason D.F. Histologic grading and clinical staging of prostatic adenocarcinoma. Tannenbaum M. Urologic pathology The prostate . 1977;171-197 Lea & Febiger, Philadelphia.
20. Zelefsky M.J., Happersett L., Leibel S.A., et al. The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 37:1997;13-19.
21. Zelefsky M.J., Harrison A. Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer Reducing the potential morbidity of therapy . Urology. 49:1997;38-45.
22. Crook J.M., Bahdur Y.A., Robertson S.J., et al. Evaluation of radiation effect, tumor differentiation and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma. Cancer. 79:1997;81-89.
23. Prestidge B.R., Hoak D.C., Grimm P.D., et al. Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer. Int J Radiat Oncol Biol Phys. 37:(1):1997;31-39.
24. Crook J.M., Perry G.A., Robertson S., Esche B.A. Routine prostate biopsies following radiotherapy for prostate cancer Results for 226 patients . Urology. 45:(4):1995;624-632.
25. Mohan R., Barest G., Brewster L.J., et al. A comprehensive three-dimensional radiation treatment planning system. Int J Radiat Oncol Biol Phys. 15:1988;481-495.
26. Press W.H., Teukolsky S.A. Quasi- (that is, sub- ) random numbers. Computers Physics. 3:1989;76-79.
27. Fowler J.F. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 62:1989;679-694.
28. Algan Ö., Stobbe C.C., Helt A.M., et al. Radiation inactivation of human prostate cancer cells The role of apoptosis . Radiat Res. 146:1996;267-275.
29. Brenner D.J., Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys. 43:1999;1095-1101.
30. Wheldon T.E., Deehan C., Wheldon E.G., Barrett A. The linear-quadratic transformation of dose-volume histograms in fractionated radiotherapy. Radiother Oncol. 46:1998;285-295.
31. Sanchez-Nieto B., Nahum A.E. The delta-TCP concept A clinically useful measure of tumor control probability . Int J Radiat Oncol Biol Phys. 44:1999;369-380.
32. Hanks G.E., Martz K.L., Diamond J.J. The effect of dose on local control of prostate cancer. Int J Radiat Oncol Biol Phys. 15:1988;1299-1305.
33. Zelefsky M.J., Leibel S.A., Kutcher G.J., et al. The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma. Cancer J Sci Am. 1:1995;42-50.
34. Matthews D, Farewell V. Using and understanding medical statistics. Vol. 3. New York: Karger; 1996.
35. Venkatraman E.S., Begg C. A distribution-free procedure for comparing receiver operating characteristic curves from a paired experiment. Biometrika. 83:1996;835-848.
36. Mohan R., Mageras G.S., Baldwin B., et al. Clinically relevant optimazation of 3-D conformal treatments. Med Phys. 19:1992;933-944.